Scott Perlman Received Approval from the FDA for the Clinical Use of 18F-Fluorocholine PET/CT in Patients with Parathyroid Adenomas
Scott Perlman, MD, MS recently received approval by the Food and Drug Administration (FDA) to use 18F-Fluorocholine to improve detection and localization of parathyroid adenomas that had previously been difficult to localize. Dr. Perlman and the Nuclear Medicine & Molecular Imaging resident Josiah Magnusson, MD collaborated with a cross-disciplinary team, including Department of Surgery Chief …